These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 37358044)
1. Novel valproate half-sandwich rhodium and iridium conjugates to fight against multidrug-resistant Gram-positive bacteria. Marco A; Vigueras G; Busto N; Cutillas N; Bautista D; Ruiz J Dalton Trans; 2023 Oct; 52(38):13482-13486. PubMed ID: 37358044 [TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity of rhodium, iridium, and ruthenium tripodal phosphine complexes. Sülü M; Küçükbay H; Durmaz R; Günal S Arzneimittelforschung; 1998 Mar; 48(3):291-3. PubMed ID: 9553688 [TBL] [Abstract][Full Text] [Related]
3. Inert cationic iridium(III) complexes with phenanthroline-based ligands: application in antimicrobial inactivation of multidrug-resistant bacterial strains. Busto N; Vigueras G; Cutillas N; García B; Ruiz J Dalton Trans; 2022 Jun; 51(25):9653-9663. PubMed ID: 35713595 [TBL] [Abstract][Full Text] [Related]
4. Novel half-sandwich rhodium(III) and iridium(III) photosensitizers for dual chemo- and photodynamic therapy. Su W; Luo Z; Dong S; Chen X; Xiao JA; Peng B; Li P Photodiagnosis Photodyn Ther; 2019 Jun; 26():448-454. PubMed ID: 31048016 [TBL] [Abstract][Full Text] [Related]
5. Half-sandwich ruthenium(II), rhodium(III) and iridium(III) fluorescent metal complexes containing pyrazoline based ligands: DNA binding, cytotoxicity and antibacterial activities. Nongpiur CGL; Verma AK; Singh RK; Ghate MM; Poluri KM; Kaminsky W; Kollipara MR J Inorg Biochem; 2023 Jan; 238():112059. PubMed ID: 36345069 [TBL] [Abstract][Full Text] [Related]
6. Targeting Multiresistant Gram-Positive Bacteria by Ruthenium, Osmium, Iridium and Rhodium Half-Sandwich Type Complexes With Bidentate Monosaccharide Ligands. Balázs B; Tóth Z; Kacsir I; Sipos A; Buglyó P; Somsák L; Bokor É; Kardos G; Bai P Front Chem; 2022; 10():868234. PubMed ID: 35494644 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship studies of antiplasmodial cyclometallated ruthenium(II), rhodium(III) and iridium(III) complexes of 2-phenylbenzimidazoles. Rylands LI; Welsh A; Maepa K; Stringer T; Taylor D; Chibale K; Smith GS Eur J Med Chem; 2019 Jan; 161():11-21. PubMed ID: 30342422 [TBL] [Abstract][Full Text] [Related]
8. Studies of antibacterial activity of binuclear rhodium (II) complexes with heterocyclic nitrogen ligands. Bień M; Pruchnik FP; Seniuk A; Lachowicz TM; Jakimowicz P J Inorg Biochem; 1999; 73(1-2):49-55. PubMed ID: 10212994 [TBL] [Abstract][Full Text] [Related]
9. New mixed ligand zinc(II) complexes based on the antiepileptic drug sodium valproate and bioactive nitrogen-donor ligands. Synthesis, structure and biological properties. Darawsheh M; Abu Ali H; Abuhijleh AL; Rappocciolo E; Akkawi M; Jaber S; Maloul S; Hussein Y Eur J Med Chem; 2014 Jul; 82():152-63. PubMed ID: 24904962 [TBL] [Abstract][Full Text] [Related]
11. The activity of platinum, iridium and rhodium drug complexes against Leishmania donovani. Croft SL; Neal RA; Craciunescu DG; Certad-Fombona G Trop Med Parasitol; 1992 Mar; 43(1):24-8. PubMed ID: 1598504 [TBL] [Abstract][Full Text] [Related]
12. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity. Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251 [TBL] [Abstract][Full Text] [Related]
13. Bioactive half-sandwich Rh and Ir bipyridyl complexes containing artemisinin. Chellan P; Avery VM; Duffy S; Land KM; Tam CC; Kim JH; Cheng LW; Romero-Canelón I; Sadler PJ J Inorg Biochem; 2021 Jun; 219():111408. PubMed ID: 33826972 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents. Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889 [TBL] [Abstract][Full Text] [Related]
15. Half-Sandwich Iridium(III), Rhodium(III), and Ruthenium(II) Complexes Chelating Hybrid sp Guo L; Li P; Li J; Gong Y; Li X; Liu Y; Yu K; Liu Z Inorg Chem; 2023 Sep; 62(37):15118-15137. PubMed ID: 37671819 [TBL] [Abstract][Full Text] [Related]
16. Group 9 organometallic compounds for therapeutic and bioanalytical applications. Ma DL; Chan DS; Leung CH Acc Chem Res; 2014 Dec; 47(12):3614-31. PubMed ID: 25369127 [TBL] [Abstract][Full Text] [Related]
17. Design of luminescent biotinylation reagents derived from cyclometalated iridium(III) and rhodium(III) bis(pyridylbenzaldehyde) complexes. Leung SK; Kwok KY; Zhang KY; Lo KK Inorg Chem; 2010 Jun; 49(11):4984-95. PubMed ID: 20465281 [TBL] [Abstract][Full Text] [Related]
19. Increasing Anticancer Activity with Phosphine Ligation in Zwitterionic Half-Sandwich Iridium(III), Rhodium(III), and Ruthenium(II) Complexes. Hu X; Guo L; Liu M; Zhang Q; Gong Y; Sun M; Feng S; Xu Y; Liu Y; Liu Z Inorg Chem; 2022 Dec; 61(49):20008-20025. PubMed ID: 36426422 [TBL] [Abstract][Full Text] [Related]
20. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents. Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]